Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 1697.69 Million | USD 3567.19 Million | 8.6% | 2023 |
The global Allergy Immunotherapy Market size was worth around USD 1697.69? million in 2023 and is predicted to grow to around USD 3567.19 million by 2032 with a compound annual growth rate (CAGR) of roughly 8.6% between 2024 and 2032.
The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD million). The report covers a forecast and an analysis of the Allergy Immunotherapy Market on a global and regional level.
Allergy immunotherapy is a type of immunotherapy where the person suffering from certain any kind of allergy is exposed to a particular type of allergen till the time his/her immune system modifies. The main aim of immunotherapy is to desensitize one’s immune system against a particular allergen, which triggers the allergy.
According to the American College of Allergy, Asthma, and Immunology, allergies are the sixth leading cause of chronic illness in North America. According to the CDC, above 50 million Americans suffer from different types of allergies annually. The increasing number of patients suffering from different types of allergies, rising government investments is fueling the global allergy immunotherapy market. Additionally, the growing R&D activities by companies for developing new technologies, rising awareness about the efficiency of allergy immunotherapies, and increasing population that is prone to allergies due to various diseases are some other factors fueling the allergy immunotherapy market globally. However, the lack of skilled professionals and high technological cost may hamper this market’s development.
The study provides a decisive view of the allergy immunotherapy market by segmenting it on the basis of treatment type, allergy type, distribution channel, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2024 to 2032.
Based on treatment type, the market includes subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT). The SCIT segment is anticipated to dominate the market in the years ahead, owing to its effectiveness to treat various allergies like asthma.
By allergy type, the market for allergy immunotherapy is divided into asthma, venom allergy, food allergy, allergic rhinitis, and others. Allergic rhinitis is expected to dominate the market for allergy immunotherapy. The asthma segment is expected to show a higher growth rate in the future, owing to the growing asthma prevalence worldwide.
The distribution channel segment of the allergy immunotherapy market comprises retail pharmacy and drug stores, online pharmacy, and hospital pharmacy.
Report Attributes | Report Details |
---|---|
Report Name | Allergy Immunotherapy Market |
Market Size in 2023 | USD 1697.69 Million |
Market Forecast in 2032 | USD 3567.19 Million |
Growth Rate | CAGR of 8.6% |
Number of Pages | 110 |
Key Companies Covered | Abello, Aimmune Therapeutics, Stallergenes Greer, Allergy Therapeutics, Biomay, Merck, DBV Technologies, Circassia, HAL Allergy, and Anergis |
Segments Covered | By treatment type, By allergy type, By distribution channel and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Europe is projected to dominate the allergy immunotherapy market, owing to the early introduction of immunotherapy treatments, an increasing geriatric population that is prone to different allergies, and rising number of supportive reimbursement policies by the government. The Asia Pacific allergy immunotherapy market is anticipated to show the highest growth rate in the upcoming years, owing to the rising investments and funding by government for R&D, increasing number of people suffering from allergies, and growing awareness about the benefits of allergy immunotherapy to treat various allergies.
Some major players involved in the global allergy immunotherapy market are:
Global Allergy Immunotherapy Market: Treatment Type Analysis
Global Allergy Immunotherapy Market: Allergy Type Analysis
Global Allergy Immunotherapy Market: Distribution Channel Analysis
Global Allergy Immunotherapy Market: Regional Analysis
FrequentlyAsked Questions
Allergy immunotherapy is a type of immunotherapy where the person suffering from certain any kind of allergy is exposed to a particular type of allergen till the time his/her immune system modifies.
According to study, the Allergy Immunotherapy Market size was worth around USD 1697.69 million in 2023 and is predicted to grow to around USD 3567.19 million by 2032.
The CAGR value of Allergy Immunotherapy Market is expected to be around 8.6% during 2024-2032.
Europe has been leading the Allergy Immunotherapy Market and is anticipated to continue on the dominant position in the years to come.
The Allergy Immunotherapy Market is led by players like Abello, Aimmune Therapeutics, Stallergenes Greer, Allergy Therapeutics, Biomay, Merck, DBV Technologies, Circassia, HAL Allergy, and Anergis.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed